Display options
Cite
Veluchamy JP, Lopez-Lastra S, Spanholtz J, et al. . Front Immunol. 2017;8:87doi: 10.3389/fimmu.2017.00087.
Veluchamy, J. P., Lopez-Lastra, S., Spanholtz, J., Bohme, F., Kok, N., Heideman, D. A., Verheul, H. M., Di Santo, J. P., de Gruijl, T. D., & van der Vliet, H. J. (2017). . Frontiers in immunology, 887. https://doi.org/10.3389/fimmu.2017.00087
Veluchamy, John P, et al. "." Frontiers in immunology vol. 8 (2017): 87. doi: https://doi.org/10.3389/fimmu.2017.00087
Veluchamy JP, Lopez-Lastra S, Spanholtz J, Bohme F, Kok N, Heideman DA, Verheul HM, Di Santo JP, de Gruijl TD, van der Vliet HJ. . Front Immunol. 2017 Feb 06;8:87. doi: 10.3389/fimmu.2017.00087. eCollection 2017. PMID: 28220124; PMCID: PMC5292674.
Copy Download .nbib Format: NLM
Share it on

Front Immunol. 2017 Feb 06;8:87. doi: 10.3389/fimmu.2017.00087. eCollection 2017.

[No title available]

Frontiers in immunology

John P Veluchamy, Silvia Lopez-Lastra, Jan Spanholtz, Fenna Bohme, Nina Kok, Daniëlle A M Heideman, Henk M W Verheul, James P Di Santo, Tanja D de Gruijl, Hans J van der Vliet

Affiliations

  1. Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, Netherlands; Glycostem Therapeutics, Oss, Netherlands.
  2. Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1223, Paris, France; Université Paris-Sud (Paris-Saclay), Paris, France.
  3. Glycostem Therapeutics , Oss , Netherlands.
  4. Department of Pathology, VU University Medical Center , Amsterdam , Netherlands.
  5. Department of Medical Oncology, VU University Medical Center, Cancer Center Amsterdam , Amsterdam , Netherlands.
  6. Innate Immunity Unit, Institut Pasteur, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) U1223, Paris, France.

PMID: 28220124 PMCID: PMC5292674 DOI: 10.3389/fimmu.2017.00087

Abstract

Therapeutic monoclonal antibodies against the epidermal growth factor receptor (EGFR) act by inhibiting EGFR downstream signaling and by eliciting a natural killer (NK) cell-mediated antitumor response. The IgG

Keywords: A-PBNK; EGFR; RAS mutation; UCB-NK; allogeneic NK cell immunotherapy; cetuximab; metastatic colorectal cancer

References

  1. Clin Cancer Res. 2008 Jul 15;14(14):4650-7 - PubMed
  2. Int J Colorectal Dis. 2011 Jul;26(7):823-33 - PubMed
  3. Clin Cancer Res. 2011 Feb 15;17(4):678-89 - PubMed
  4. Ann Oncol. 2015 Jan;26(1):13-21 - PubMed
  5. Mol Cancer Ther. 2012 Dec;11(12):2674-84 - PubMed
  6. PLoS One. 2016 Jun 17;11(6):e0157830 - PubMed
  7. Mol Immunol. 2005 Feb;42(4):541-6 - PubMed
  8. Expert Opin Drug Saf. 2009 Mar;8(2):223-35 - PubMed
  9. Clin Transl Oncol. 2010 Aug;12 (8):533-42 - PubMed
  10. Anticancer Res. 2004 May-Jun;24(3b):1861-71 - PubMed
  11. J Immunother. 2000 Jan;23(1):154-60 - PubMed
  12. J Transl Med. 2013 Oct 20;11:262 - PubMed
  13. Clin Cancer Res. 2008 Jun 1;14(11):3520-8 - PubMed
  14. PLoS One. 2010 Feb 15;5(2):e9221 - PubMed
  15. Immunogenetics. 2011 Feb;63(2):65-71 - PubMed
  16. Cytotherapy. 2011 Jan;13(1):98-107 - PubMed
  17. N Engl J Med. 1997 Aug 7;337(6):373-81 - PubMed
  18. N Engl J Med. 2008 Oct 23;359(17):1757-65 - PubMed
  19. Blood. 2005 Apr 15;105(8):3051-7 - PubMed
  20. PLoS One. 2013 Jun 05;8(6):e64384 - PubMed
  21. Cancer. 1997 Jun 15;79(12):2320-8 - PubMed
  22. Nat Rev Drug Discov. 2004 Jul;3(7):549-50 - PubMed
  23. Clin Cancer Res. 2011 Oct 1;17(19):6287-97 - PubMed
  24. Nat Immunol. 2008 May;9(5):503-10 - PubMed
  25. J Surg Oncol. 1997 Apr;64(4):324-30 - PubMed
  26. Front Immunol. 2015 Jul 27;6:368 - PubMed
  27. Immunol Today. 1990 Jul;11(7):237-44 - PubMed
  28. Lung Cancer. 2002 Jan;35(1):23-8 - PubMed
  29. Cell Mol Immunol. 2013 May;10(3):230-52 - PubMed
  30. Crit Rev Oncog. 2014;19(1-2):91-105 - PubMed
  31. Adv Cancer Res. 2006;95:293-322 - PubMed
  32. Annu Rev Immunol. 1998;16:359-93 - PubMed
  33. Blood. 2012 Jun 14;119(24):5758-68 - PubMed
  34. Nat Immunol. 2008 May;9(5):486-94 - PubMed
  35. Cancer. 2000 Feb 1;88(3):577-83 - PubMed
  36. J Hematol Oncol. 2015 Aug 01;8:96 - PubMed
  37. Nat Protoc. 2009;4(4):582-91 - PubMed
  38. Stem Cells Dev. 2012 Nov 1;21(16):2926-38 - PubMed
  39. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  40. Int J Cancer. 1975 Aug 15;16(2):216-29 - PubMed
  41. J Clin Oncol. 2015 Jun 1;33(16):1809-24 - PubMed
  42. Medicine (Baltimore). 2008 Sep;87(5):259-63 - PubMed
  43. Annu Rev Immunol. 2001;19:197-223 - PubMed
  44. Drugs. 2010;70(2):215-39 - PubMed

Publication Types